-
1
-
-
0020424709
-
Synthesis, turnover and down-regulation of epidermal growth factor receptors in human A431 epidermal carcinoma cells and skin fibroblasts
-
1. Krupp MN, Connolly DT, Lane MD: Synthesis, turnover and down-regulation of epidermal growth factor receptors in human A431 epidermal carcinoma cells and skin fibroblasts. J Biol Chem 257: 11489-11496, 1982
-
(1982)
J Biol Chem
, vol.257
, pp. 11489-11496
-
-
Krupp, M.N.1
Connolly, D.T.2
Lane, M.D.3
-
2
-
-
0024355092
-
Autocrine interaction between TGFα and EGF-receptor: Quantitative requirements for induction of the malignant phenotype
-
2. Di Marco R, Pierce JH, Fleming TP, Kraus MH, Molloy CJ, Aaronson SA, Di Fiore PP: Autocrine interaction between TGFα and EGF-receptor: quantitative requirements for induction of the malignant phenotype. Oncogene 4: 831-839, 1990
-
(1990)
Oncogene
, vol.4
, pp. 831-839
-
-
Di Marco, R.1
Pierce, J.H.2
Fleming, T.P.3
Kraus, M.H.4
Molloy, C.J.5
Aaronson, S.A.6
Di Fiore, P.P.7
-
3
-
-
0025063944
-
Expression of the transforming growth factor-α/epidermal growth factor receptor pathway in normal human breast epithelial cells
-
3. Bates SE, Valverius EM, Ennis BW, Bronzert DA, Sheridan JP, Stampfer MR, Mendelsohn J, Lippman ME, Dickson RB: Expression of the transforming growth factor-α/epidermal growth factor receptor pathway in normal human breast epithelial cells. Endocrinol 126: 596-607, 1990
-
(1990)
Endocrinol
, vol.126
, pp. 596-607
-
-
Bates, S.E.1
Valverius, E.M.2
Ennis, B.W.3
Bronzert, D.A.4
Sheridan, J.P.5
Stampfer, M.R.6
Mendelsohn, J.7
Lippman, M.E.8
Dickson, R.B.9
-
4
-
-
0024350186
-
Epidermal growth factor receptor and oestrogen receptors in the non-malignant part of the cancerous breast
-
4. Barker S, Panahy C, Puddefoot JR, Goode AW, Vinson GP: Epidermal growth factor receptor and oestrogen receptors in the non-malignant part of the cancerous breast. Br J Cancer 60: 673-677, 1989
-
(1989)
Br J Cancer
, vol.60
, pp. 673-677
-
-
Barker, S.1
Panahy, C.2
Puddefoot, J.R.3
Goode, A.W.4
Vinson, G.P.5
-
5
-
-
0027464054
-
Epidermal growth factor receptor in breast cancer. Comparison with non-malignant breast tissue
-
5. Dittadi R, Donisi PM, Brazzale A, Capellozza L, Bruscagnin G, Gion M: Epidermal growth factor receptor in breast cancer. Comparison with non-malignant breast tissue. Br J Cancer 67: 7-9, 1993
-
(1993)
Br J Cancer
, vol.67
, pp. 7-9
-
-
Dittadi, R.1
Donisi, P.M.2
Brazzale, A.3
Capellozza, L.4
Bruscagnin, G.5
Gion, M.6
-
6
-
-
0025307066
-
Neu oncogene and epidermal growth factor receptor are independently expressed in benign and malignant tissues
-
6. Tsutsumi Y, Naber SP, DeLellis RA, Wolfe HJ, Marks PJ, McKenzie SJ, Yin S: Neu oncogene and epidermal growth factor receptor are independently expressed in benign and malignant tissues. Hum Pathol 21: 750-758, 1990
-
(1990)
Hum Pathol
, vol.21
, pp. 750-758
-
-
Tsutsumi, Y.1
Naber, S.P.2
DeLellis, R.A.3
Wolfe, H.J.4
Marks, P.J.5
McKenzie, S.J.6
Yin, S.7
-
7
-
-
38249012899
-
Oestrogen receptor, epidermal growth factor receptor and oncoprotein expression in non-involved tissue of cancerous breasts
-
7. Walker RA, Cowl J, Dhadly PP, Jones JL: Oestrogen receptor, epidermal growth factor receptor and oncoprotein expression in non-involved tissue of cancerous breasts. Breast 2: 87-91, 1992
-
(1992)
Breast
, vol.2
, pp. 87-91
-
-
Walker, R.A.1
Cowl, J.2
Dhadly, P.P.3
Jones, J.L.4
-
8
-
-
0028223731
-
Differential expression of oestrogen, progesterone and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry
-
8. van Agthoven T, Timmermans M, Foekens JA, Dorssers LCJ, Henzen-Logmans SC: Differential expression of oestrogen, progesterone and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry. Am J Pathol 144: 1238-1246, 1994
-
(1994)
Am J Pathol
, vol.144
, pp. 1238-1246
-
-
Van Agthoven, T.1
Timmermans, M.2
Foekens, J.A.3
Dorssers, L.C.J.4
Henzen-Logmans, S.C.5
-
9
-
-
9244238211
-
Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle
-
9. Gompel A, Martin A, Simon P, Schoevaert D, Plu-Bureau G, Hugol D, Andouin J, Leygue E, Truc JB, Poitout PL: Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle. Breast Cancer Res Treat 38: 227-235, 1996
-
(1996)
Breast Cancer Res Treat
, vol.38
, pp. 227-235
-
-
Gompel, A.1
Martin, A.2
Simon, P.3
Schoevaert, D.4
Plu-Bureau, G.5
Hugol, D.6
Andouin, J.7
Leygue, E.8
Truc, J.B.9
Poitout, P.L.10
-
10
-
-
0026571910
-
The clinical significance of epidermal growth factor in human breast cancer. A review on 5232 patients
-
10. Klijn JGM, Berns PMJJ, Schmitz PIM, Foekens JA: The clinical significance of epidermal growth factor in human breast cancer. A review on 5232 patients. Endocr Rev 13: 3-17, 1992
-
(1992)
Endocr Rev
, vol.13
, pp. 3-17
-
-
Klijn, J.G.M.1
Berns, P.M.J.J.2
Schmitz, P.I.M.3
Foekens, J.A.4
-
11
-
-
0021911679
-
Epidermal growth factor receptor in human breast cancer
-
11. Sainsbury JRC, Farndon JR, Sherbet GV, Harris AL: Epidermal growth factor receptor in human breast cancer. Lancet i: 364-366, 1985
-
(1985)
Lancet
, vol.1
, pp. 364-366
-
-
Sainsbury, J.R.C.1
Farndon, J.R.2
Sherbet, G.V.3
Harris, A.L.4
-
12
-
-
0022444366
-
DNA flow cytometry of human breast carcinomas and its relationship to transferrin and epidermal growth factor receptors
-
12. Walker RA, Camplejohn RS: DNA flow cytometry of human breast carcinomas and its relationship to transferrin and epidermal growth factor receptors. J Pathol 150: 37-42, 1986
-
(1986)
J Pathol
, vol.150
, pp. 37-42
-
-
Walker, R.A.1
Camplejohn, R.S.2
-
13
-
-
0027309375
-
Relationship between EGF-R, c-erbB-2 protein expression and Ki 67 immunostaining in breast cancer and hormone sensitivity
-
13. Nicholson RI, McClelland RA, Finlay P, Eaton CL, Gullick WL, Dixon AR, Robertson JFR, Ellis IO, Blamey RW: Relationship between EGF-R, c-erbB-2 protein expression and Ki 67 immunostaining in breast cancer and hormone sensitivity. Eur J Cancer 29A: 1018-1023, 1993
-
(1993)
Eur J Cancer
, vol.29 A
, pp. 1018-1023
-
-
Nicholson, R.I.1
McClelland, R.A.2
Finlay, P.3
Eaton, C.L.4
Gullick, W.L.5
Dixon, A.R.6
Robertson, J.F.R.7
Ellis, I.O.8
Blamey, R.W.9
-
14
-
-
0028293921
-
Epidermal growth factor receptor expression in breast cancer: Association with responses to endocrine therapy
-
14. Nicholson RI, McClelland RA, Gee JMW, Manning DL, Cannon P, Robertson JFR, Ellis IO, Blamey RW: Epidermal growth factor receptor expression in breast cancer: association with responses to endocrine therapy. Breast Cancer Res Treat 29: 117-125, 1994
-
(1994)
Breast Cancer Res Treat
, vol.29
, pp. 117-125
-
-
Nicholson, R.I.1
McClelland, R.A.2
Gee, J.M.W.3
Manning, D.L.4
Cannon, P.5
Robertson, J.F.R.6
Ellis, I.O.7
Blamey, R.W.8
-
15
-
-
0024531977
-
Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer
-
15. Nicholson S, Sainsbury JRC, Halcrow P, Chambers P, Farndon JR, Harris AL: Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer. Lancet i: 182-184, 1989
-
(1989)
Lancet
, vol.1
, pp. 182-184
-
-
Nicholson, S.1
Sainsbury, J.R.C.2
Halcrow, P.3
Chambers, P.4
Farndon, J.R.5
Harris, A.L.6
-
16
-
-
0023279839
-
Epidermal growth factor receptor status as predictor of early recurrence and death from breast cancer
-
16. Sainsbury JRC, Farndon JR, Needham GK, Malcolm AJ, Harris AL: Epidermal growth factor receptor status as predictor of early recurrence and death from breast cancer. Lancet i: 1398-1402, 1987
-
(1987)
Lancet
, vol.1
, pp. 1398-1402
-
-
Sainsbury, J.R.C.1
Farndon, J.R.2
Needham, G.K.3
Malcolm, A.J.4
Harris, A.L.5
-
17
-
-
0026075994
-
Epidermal growth factor receptor negative tumours are predominantly confined to the subgroup of oestradiol receptor positive human primary breast cancers
-
17. Koenders PG, Beex LVAM, Geurts-Moespot A, Heuvel JJTM, Kienhuis CMB, Benraad TJ: Epidermal growth factor receptor negative tumours are predominantly confined to the subgroup of oestradiol receptor positive human primary breast cancers. Cancer Res 51: 4544-4548, 1981
-
(1981)
Cancer Res
, vol.51
, pp. 4544-4548
-
-
Koenders, P.G.1
Beex, L.V.A.M.2
Geurts-Moespot, A.3
Heuvel, J.J.T.M.4
Kienhuis, C.M.B.5
Benraad, T.J.6
-
18
-
-
0026735186
-
Immunocytochemistry and in situ hybridization of epidermal growth factor receptor and relation to prognostic factors in breast cancer
-
18. Bilous M, Milliken J, Mathijs J-M: Immunocytochemistry and in situ hybridization of epidermal growth factor receptor and relation to prognostic factors in breast cancer. Eur J Cancer 28A: 1023-1038, 1992
-
(1992)
Eur J Cancer
, vol.28 A
, pp. 1023-1038
-
-
Bilous, M.1
Milliken, J.2
Mathijs, J.-M.3
-
19
-
-
0023304864
-
Epidermal growth factor gene expression in estrogen receptor positive and negative human breast cancer cell lines
-
19. Davidson NE, Gelmann EP, Lippman ME, Dickson RB: Epidermal growth factor gene expression in estrogen receptor positive and negative human breast cancer cell lines. Mol Endocrinol 1: 216-233, 1987
-
(1987)
Mol Endocrinol
, vol.1
, pp. 216-233
-
-
Davidson, N.E.1
Gelmann, E.P.2
Lippman, M.E.3
Dickson, R.B.4
-
20
-
-
0023908327
-
Growth factor expression in normal, benign and malignant breast tissue
-
20. Travers MT, Barrett-Lee PJ, Berger U, Luqmani YA, Gazet JC, Powles TJ, Coombes RC: Growth factor expression in normal, benign and malignant breast tissue. Br Med J 296: 1621-1624, 1988
-
(1988)
Br Med J
, vol.296
, pp. 1621-1624
-
-
Travers, M.T.1
Barrett-Lee, P.J.2
Berger, U.3
Luqmani, Y.A.4
Gazet, J.C.5
Powles, T.J.6
Coombes, R.C.7
-
21
-
-
0026072872
-
Pathological prognostic factors in breast cancer, I. The value of histological grade in breast cancer: Experience from a large study with long term follow up
-
21. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer, I. The value of histological grade in breast cancer: experience from a large study with long term follow up. Histopathol 19: 403-410, 1991
-
(1991)
Histopathol
, vol.19
, pp. 403-410
-
-
Elston, C.W.1
Ellis, I.O.2
-
22
-
-
0020261008
-
A monoclonal antibody to the human epidermal growth factor receptor
-
22. Waterfield MD, Mayes ELV, Stroobaut P, Bennett PLP, Young S, Goodfellow RN, Banting GS, Ozanne B: A monoclonal antibody to the human epidermal growth factor receptor. J Cell Biochem 20: 149-161, 1982
-
(1982)
J Cell Biochem
, vol.20
, pp. 149-161
-
-
Waterfield, M.D.1
Mayes, E.L.V.2
Stroobaut, P.3
Bennett, P.L.P.4
Young, S.5
Goodfellow, R.N.6
Banting, G.S.7
Ozanne, B.8
-
23
-
-
0028873366
-
Pathological and biological features of mammographically detected invasive breast carcinomas
-
23. Rajakariar R, Walker RA: Pathological and biological features of mammographically detected invasive breast carcinomas. Br J Cancer 71: 150-154, 1995
-
(1995)
Br J Cancer
, vol.71
, pp. 150-154
-
-
Rajakariar, R.1
Walker, R.A.2
-
24
-
-
0029827294
-
E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma
-
24. Jones JL, Royall JE, Walker RA: E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. Br J Cancer 74: 1237-1241, 1996
-
(1996)
Br J Cancer
, vol.74
, pp. 1237-1241
-
-
Jones, J.L.1
Royall, J.E.2
Walker, R.A.3
-
25
-
-
0021273420
-
Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermal carcinoma cells
-
25. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlesinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, SeeburgPH: Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermal carcinoma cells. Nature 309: 418-425, 1984
-
(1984)
Nature
, vol.309
, pp. 418-425
-
-
Ullrich, A.1
Coussens, L.2
Hayflick, J.S.3
Dull, T.J.4
Gray, A.5
Tam, A.W.6
Lee, J.7
Yarden, Y.8
Libermann, T.A.9
Schlesinger, J.10
Downward, J.11
Mayes, E.L.V.12
Whittle, N.13
Waterfield, M.D.14
Seeburg, P.H.15
-
26
-
-
0002809190
-
Non-isotopic detection of RNA in situ
-
Levy ER, Herrington CS (eds). IRL, Oxford
-
26. Pringle JH: Non-isotopic detection of RNA in situ. In: Levy ER, Herrington CS (eds) Non-isotopic Methods in Molecular Biology. IRL, Oxford, 1995, pp 85-110
-
(1995)
Non-isotopic Methods in Molecular Biology
, pp. 85-110
-
-
Pringle, J.H.1
-
27
-
-
4243846034
-
Comparison of epidermal growth factor expression in non-involved tissue of cancer-containing breast with normal/benign breast
-
27. Hassan HI, Walker RA: Comparison of epidermal growth factor expression in non-involved tissue of cancer-containing breast with normal/benign breast. J Pathol 178: 24A, 1996
-
(1996)
J Pathol
, vol.178
-
-
Hassan, H.I.1
Walker, R.A.2
-
28
-
-
0023949462
-
Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinomas
-
28. Ro J, North SM, Gallick GE, Hortobagyi GN, Gutterman JU, Blick M: Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinomas. Cancer Res 48: 161-164, 1988
-
(1988)
Cancer Res
, vol.48
, pp. 161-164
-
-
Ro, J.1
North, S.M.2
Gallick, G.E.3
Hortobagyi, G.N.4
Gutterman, J.U.5
Blick, M.6
-
29
-
-
0027254405
-
The prognostic significance of transforming growth factors in human breast cancer
-
29. Murray PA, Barrett-Lee P, Travers M, Luqmani Y, Powles T, Coombes RC: The prognostic significance of transforming growth factors in human breast cancer. Br J Cancer 67: 1408-1413, 1993
-
(1993)
Br J Cancer
, vol.67
, pp. 1408-1413
-
-
Murray, P.A.1
Barrett-Lee, P.2
Travers, M.3
Luqmani, Y.4
Powles, T.5
Coombes, R.C.6
-
30
-
-
0022638071
-
Progesterone regulation of epidermal growth factor receptor in human mammary carcinoma cells
-
30. Murphy LJ, Sutherland RL, Murphy LC, Lazarus L: Progesterone regulation of epidermal growth factor receptor in human mammary carcinoma cells. Cancer Res 46: 728-734, 1986
-
(1986)
Cancer Res
, vol.46
, pp. 728-734
-
-
Murphy, L.J.1
Sutherland, R.L.2
Murphy, L.C.3
Lazarus, L.4
-
31
-
-
0024459250
-
Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines
-
31. Ewing TM, Murphy LJ, Ng M-L, Pang GYN, Lee CSL, Watts CKW, Sutherland RL: Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines. Int J Cancer 44: 744-752, 1989
-
(1989)
Int J Cancer
, vol.44
, pp. 744-752
-
-
Ewing, T.M.1
Murphy, L.J.2
Ng, M.-L.3
Pang, G.Y.N.4
Lee, C.S.L.5
Watts, C.K.W.6
Sutherland, R.L.7
-
32
-
-
0030010812
-
Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells
-
32. Yarden RI, Lauber AH, EI Ashry D, Chrysogelos SA: Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells. Endocrinol 137: 2739-2747, 1996
-
(1996)
Endocrinol
, vol.137
, pp. 2739-2747
-
-
Yarden, R.I.1
Lauber, A.H.2
Ei Ashry, D.3
Chrysogelos, S.A.4
-
33
-
-
0030795062
-
Antisense estrogen receptor RNA expression increases epidermal growth factor receptor gene expression in breast cancer cells
-
33. de Fazio A, Chiew YE, McEvoy M, Watts CKW, Sutherland RL: Antisense estrogen receptor RNA expression increases epidermal growth factor receptor gene expression in breast cancer cells. Cell Growth Different 8: 903-911, 1997
-
(1997)
Cell Growth Different
, vol.8
, pp. 903-911
-
-
De Fazio, A.1
Chiew, Y.E.2
McEvoy, M.3
Watts, C.K.W.4
Sutherland, R.L.5
-
34
-
-
0025077072
-
Overexpression of the epidermal growth factor receptor in human breast cancer cells fails to induce an estrogen-independent phenotype
-
34. Valverius EM, Velu T, Shankar V, Ciardiello F, Kim N, Salomon DS: Overexpression of the epidermal growth factor receptor in human breast cancer cells fails to induce an estrogen-independent phenotype. Int J Cancer 46: 712-718, 1990
-
(1990)
Int J Cancer
, vol.46
, pp. 712-718
-
-
Valverius, E.M.1
Velu, T.2
Shankar, V.3
Ciardiello, F.4
Kim, N.5
Salomon, D.S.6
-
35
-
-
0028072243
-
Mechanisms of EGF receptor regulation in breast cancer cells
-
35. Chrysogelos SA, Yardin RI, Lauber AH, Murphy JM: Mechanisms of EGF receptor regulation in breast cancer cells. Breast Cancer Res Treat 31: 227-236, 1994
-
(1994)
Breast Cancer Res Treat
, vol.31
, pp. 227-236
-
-
Chrysogelos, S.A.1
Yardin, R.I.2
Lauber, A.H.3
Murphy, J.M.4
|